Alkermes (ALKS) r&d spend was $324M in FY2025 (+32% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$324M
+32%
2024
$245M
-9%
2023
$271M
-1%
2022
$273M
-6%
2021
$291M
-26%
2020
$395M
-23%
2019
$513M
+21%
2018
$425M
+3%
2017
$413M
+7%
2016
$387M
+12%
2015
$344M
+27%
2014
$272M
+94%
2013
$140M
-1%
2012
$142M
+46%
2011
$97M
+2%
2010
$95M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$113M
Q1 2026
$103M
Q4 2025
$93M
Q3 2025
$82M
Q2 2025
$77M
Q1 2025
$72M
Q4 2024
$58M
Q3 2024
$60M
Q2 2024
$60M
Q1 2024
$68M
Q4 2023
$74M
Q3 2023
$65M
Source: ALKS on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.